News
Covid, Moderna and FDA
Digest more
WOODTV.com on MSN10h
Moderna gets full FDA approval for kids COVID-19 vaccineThe company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Scripps News on MSN1d
FDA approves Moderna's COVID vaccine for children as young as 6 months oldThe U.S. Food and Drug Administration approved "Spikevax," Moderna's vaccine for children aged 6 months to 11 years old. The ...
Moderna expects to have its updated Spikevax vaccine available for eligible populations in the U.S. for the 2025-2026 respiratory virus season. About Moderna.
Zacks.com on MSN1d
MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric PatientsModerna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...
Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback